MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 4, 2006; DOI: 10.1124/mol.106.026575


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.026575v1
71/1/61    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Baskaran Rajasekaran
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamath, R.
Right arrow Articles by Rajasekaran, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamath, R.
Right arrow Articles by Rajasekaran, B.


Received for publication May 11, 2006.
Revised October 3, 2006.
Accepted for publication October 3, 2006.

c-Abl kinase regulates curcumin-induced cell death through activation of JNK

Ravindra Kamath 1, Zhihua Jiang 1, Guoming Sun 1, Jack C Yalowich 1, Baskaran Rajasekaran 1*

1 University of Pittsburgh, School of Medicine

* Address correspondence to: E-mail: bask{at}pitt.edu

Abstract

Curcumin, a natural phenolic compound found in turmeric (curcuma longa) exhibits anti-cancer properties, attributed to its anti-proliferative and apoptosis-inducing activity. The ubiquitously expressed non-receptor tyrosine kinase, c-Abl regulates stress responses induced by oxidative agents such as ionizing radiation and H2O2. Here we show that c-Abl is an important component of the cell death response activated by curcumin and that Abl mediates this response, in part, through activation of JNK. Consequently, inhibition of Abl by STI571 (Imanitib, Gleevac) treatment or downregulation of Abl expression through Abl specific ShRNA diminished cell death induction and JNK activation. Highlighting the inter-dependent nature of the Abl and JNK signaling in the curcumin-induced cell death response, a JNK inhibitor (SP600125) caused very little cell death inhibition in STI571-pretreated cells and in Abl ShRNA expressing cells. Moreover, treatment with Abl and JNK inhibitor alone or together caused similar levels of cell death inhibition. Although p53 induction in response to curcumin treatment is dependent on Abl, we found that Abl->p53 signaling is dispensable for curcumin-induced cell death. Taken together, the results demonstrate the differential roles played by Abl->p53 and Abl->JNK signaling events in modulating the cell death response to curcumin.


Key words: Apoptosis, Oxidative stress/antioxidants, Mechanisms of cell killing/apoptosis


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. W. Wagner, L. S. Li, J. C. Morales, C. L. Galindo, H. R. Garner, W. G. Bornmann, and D. A. Boothman
Role of c-Abl Kinase in DNA Mismatch Repair-dependent G2 Cell Cycle Checkpoint Arrest Responses
J. Biol. Chem., August 1, 2008; 283(31): 21382 - 21393.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics